AOD9604 is associated with a defined growth-hormone fragment design. Resolve the name to sequence, terminal chemistry and molecular form before approval.
What procurement and laboratory teams should review
Confirm the expected fragment sequence
Check terminal modifications and form
Compare observed with theoretical mass
Separate vial strength from purity and identity
Define the molecular form before comparing offers
Sequence alone may not fully define a peptide material. Termini, modifications, disulfide pattern, counterion, hydration state and presentation can affect molecular-weight calculations, analytical reporting, solubility and handling.
- Record sequence, termini and every modification explicitly.
- State the requested salt or counterion form.
- Treat solubility and stability as material- and condition-specific.
Questions to resolve before quotation or release
- Which sequence does the listing represent?
- Are terminal groups in the mass calculation?
- Does the COA match the offered lot?
Multiple presentations must retain the same molecule and lot-linked evidence.
Source material and further reading
This guide is informed by the following primary guidance and established technical resources. Always confirm the current version and its applicability to your material and jurisdiction.
HK PEPTIDES materials are supplied for laboratory research and documentation workflows only. They are not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.